Remifentanil for labour analgesia should be offered as a routine option to pregnant women in labour: pro (pro-con debate)

DEWANDRE, Pierre-Yves

doi:10.1097/AAP.0000000000000656

Paper published in a journal (Scientific congresses and symposiums)

Remifentanil for labour analgesia should be offered as a routine option to pregnant women in labour: pro (pro-con debate)

DEWANDRE, Pierre-Yves

2017 • In Regional Anesthesia and Pain Medicine, 42 (5 , suppl 1), p. 16-e17

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/254316

DOI
10.1097/AAP.0000000000000656

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

ESRA-2017-Abstarcts & Highlights-Remi.pdf

Publisher postprint (132.43 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

Anesthesia & intensive care

Author, co-author :

DEWANDRE, Pierre-Yves ; Centre Hospitalier Universitaire de Liège - CHU > Département d'Anesthésie et réanimation > Service d'anesthésie - réanimation

Language :

English

Title :

Remifentanil for labour analgesia should be offered as a routine option to pregnant women in labour: pro (pro-con debate)

Publication date :

13 September 2017

Event name :

36th annual ESRA congress (European Society of Regional Anaesthesia and Pain Therapy).

Event organizer :

ESRA (European Society of Regional Anaesthesia and Pain Therapy)

Event place :

Lugano, Switzerland

Event date :

du 13 au 16 septembre 2017

By request :

Yes

Audience :

International

Journal title :

Regional Anesthesia and Pain Medicine

ISSN :

1098-7339

eISSN :

1532-8651

Publisher :

W. B. Saunders Co., United Kingdom

Volume :

Issue :

5 , suppl 1

Pages :

e16-e17

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 22 December 2020

Statistics

Number of views

54 (4 by ULiège)

Number of downloads

2 (2 by ULiège)

More statistics

OpenCitations